James Stefater

WellDoc, Inc. develops technology solutions to support chronic disease management. Its product DiabetesManager provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence. The company was founded by Ryan Sysko, Yves Nordmann and Suzanne Sysko Clough in 2005 and is headquartered in Columbia, MD.

Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ.

InfoBionic, Inc. provides wireless remote patient monitoring systems. It specializes in cardiac arrhythmia detection and analytics monitoring. The company was founded by Nancy M. Briefs, Michael Fahey, Ravi Kuppuraj and Jeremy N. Ruskin in 2011 and is headquartered in Lowell, MA.

Qpid Health, Inc. provides health record acceleration software and intelligence solutions. It develops clinical insights software for use by hospitals and medical groups. The firm’s QPID solution uses natural language processing and proprietary tools to improve how clinical and administrative users can have access to information stored in electronic health records. The company was founded by Michael Zalis and Mitchell Harris in 2011 and is headquartered in Boston, MA.

Embr Labs, Inc. operates as a research and products development company. The firm specializes in personal heating and cooling, comfort, wearable technology and design. The company was founded by David Cohen- Tanugi, Matthew J. Smith, Samuel W. L. Shames and Michael Gibson in June 2013 and is headquartered in Boston, MA.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California.

Angel Healthcare Investors LLC provides financing for businesses. It is a private equity and venture capital firm specializing in early stage ventures, turnarounds, and spin-offs. The firm typically invests in companies with a direct healthcare and life sciences application, biotechnology, bioinformatics, medical device, medical testing, analysing and diagnostic equipment and but may also consider other opportunities outside the healthcare industry. The company was founded by Alan Solomont, Susan Bailis and Dick Thielen on October 1, 1999 and is headquartered in Newton, MA.

Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA.

Mass General Brigham Ventures LLC (Mass General Brigham Ventures) is a venture capital subsidiary of Partners Research Ventures & Licensing founded in 2005. The firm is headquartered in the Cambridge, Massachusetts.

Mass Medical Angels LLC (MA2) is an angel firm founded in 2009 by Richard Anders and Roger Kitterman. The firm is headquartered in Boston, Massachusetts.

Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA.

Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ.

Kasalis, Inc. supplies advanced manufacturing systems for optoelectronics devices. Its products include camera assembly systems, selection guide, and services and support. The company was founded in 2011 and is headquartered in Burlington, MA.

DigiTx Partners LLC (DigiTx Partners) is a venture capital firm founded in 2016 by David J. Kim and Luke Evnin. The firm is headquartered in Brisbane, California.

Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA.

Iota Biosciences, Inc. provides biotechnological research and development services. The company was founded by Richard Passov, Coleman Fung and Tim Opler in 2017 and is headquartered in Berkeley, CA.

Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA.

United Immunity Co. Ltd. is a Japanese company that specializes in pipeline nano technology and immunity fusion technology, specifically in the field of cancer immunotherapy. The company is based in Tsu, Japan and was founded in 2017 by Naozumi Harada, who has been the CEO since then. The company's diverse products, including "nano immunotherapy," have shown promising clinical results and research in the treatment of sex cancer. The company is currently recruiting a researcher in the cancer immunotherapy field to analyze the action mechanism of nanotechnology applied cancer evaluation and drug evaluation using immunological methods. The company's focus is on the development of treatment for the cause of cold tumor type cancer through the understanding of tumor-associated macrophages.

Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD.

Neutrolis, Inc. is a biotechnology company located in North Cambridge, MA. The company develops first-in-class therapies that target neutrophils and their pathogenic products, including nets. Neutrolis proprietary platform, Chromatinase™, is based on the naturally occurring enzymes that break down the extracellular chromatin that form nets. The company's lead product, NTR-441, is a patented, first-in-class, engineered DNASE1L3 analog with potential application in COVID-19, ARDS, lupus, rheumatoid arthritis, systemic sclerosis, and other net-mediated diseases. Neutrolis has received two competitive LabCentral Golden Ticket awards from Pfizer and Bristol-Myers Squibb. The company was founded by Abdul Hakkim and Toby Fox. Toby Fox has been the CEO since incorporation.

Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware.

Anodyne Nanotech, Inc. operates as a preclinical-stage biotech company. It develops differentiated and transdermal forms of high-value drugs. The company is headquartered in Boston, MA.

Nesos, Inc. develops wearable ear buds and software solutions for noninvasive pain therapy. The company is based in Redwood City, CA. The company was founded by Konstantinos Alataris.

Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts.

Sequre Dx, Inc. is a genomics intelligence company that focuses on advancing on-target gene editing and cell therapies from discovery to patient. The company is based in Waltham, MA. The company offers preclinical platforms for the biopharma industry, including diagnostic assays and bioinformatic analytics that solve preclinical off-target evaluation needs. Sequre Dx aims to make gene editing and cell therapies suitable for all patients who would benefit from these life-saving technologies. The CEO of the company is Ellen E. Sheets.

InStride Health, Inc. provides evidence-based anxiety and OCD treatment for children and young adults aged 7 to 22. InStride Health is based in Wellesley, MA and was founded by Mona Potter, Kathryn Boger, James McElhiney, and John Voith. The company aims to engage kids and teens every step of the way and offers resources and information for media to learn how they help their patients connect and thrive. John Voith has been the CEO since incorporation.

Starlight Cardiovascular, Inc. is a medical device company based in San Diego, CA. Starlight Cardiovascular, Inc. develops tools and devices to treat pediatric congenital heart defects. The company was founded by Beverly Tang, Pedro del Nido, Carl M. Berke, Attila Meretei, Tom Duerig, and Beverly Tang has been the CEO since incorporation.

CodaMetrix, Inc. develops an AI-platform that translates clinical information into accurate sets of medical codes for patient care and revenue cycle processes. The company is based in Boston, MA. The company was founded in 2019. The CEO is Hamid Tabatabaie.